54

Eiko Lifesciences LtdBOM 540204 Stock Report

Last reporting period 30 Sep, 2022

Updated 11 Nov, 2024

Last price

Market cap $B

0.01

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Eiko Statements

54

Data from Eiko`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

30 Sep, 2022

Next reporting period:

29 Mar, 2023

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

06 Nov, 2024

Eiko Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2022-09-30
%

73.512

-32.4 %

100

63.201

89.7

10.311

-6.1 %

10.3

0

5.341

1.6

10.802

-2.2 %

10.6

-0.491

-691.9 %

-0.3

-1.026

-0.3

4.607

5.2

3.09

172.7 %

4.6

0.771

1.1

2.319

170.6 %

3.5

0.28

8.282

2022-03-31
%

108.72

-25.2 %

100

97.745

88.2

10.978

-36.6 %

11.8

0

7.95

7.1

11.04

11.2 %

10.1

-0.062

-100.8 %

1.8

-2.33

-2.009

3.525

3.9

1.133

-86.3 %

3.6

0.276

0.9

0.857

-86.2 %

2.8

0.107

8.511

2021-09-30
%

145.4

100

128.07

88.6

17.325

11.4

0

7.4

4.1

9.932

6.8

7.393

4.7

-2.312

-3.05

3.208

3.2

8.288

4.8

2.088

1.2

6.2

3.6

0.903

7.293

View Section: Balance Sheet